Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes

As Warner Chilcott plc (NASDAQ:WCRX) has previously disclosed, its acquisition of the global branded prescription pharmaceuticals business of The Procter & Gamble Company ("P&G") on October 30, 2009 (the "PGP Acquisition"), constituted a change of control under a global marketing and collaboration agreement (the "Marketing Agreement") between a P&G subsidiary acquired by Warner Chilcott and Sanofi-Aventis U.S. LLC ("Sanofi") relating to the development and sale of risedronate products (including Actonel®). Pursuant to the Marketing Agreement, the change of control gives Sanofi the right to exercise an option to put its interest in the Marketing Agreement to Warner Chilcott at a fair...

Want to see the full article?

• Purchase this article for only $3.00